A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself
source: pixabay.com

A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself

According to a story from Yahoo News, Dr. Nancy Wexler spent around 20 years in Venezuela conducting pivotal research on a deadly rare genetic disorder: Huntington's disease. On Lake Maracaibo,…

Continue Reading A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself
A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
source: pixabay.com

A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement

  A recent article in ANCA Vasculitis News highlighted a Chinese study of ANCA-associated vasculitis (AAV), a group of autoimmune diseases. An earlier Chinese study suggested that the risk of…

Continue Reading A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
New Research Finds That Chemotherapy After Rare Kidney Cancer Surgery Reduces Chance of Relapse
source: pixabay.com

New Research Finds That Chemotherapy After Rare Kidney Cancer Surgery Reduces Chance of Relapse

  A recent study has found that undergoing chemotherapy after having surgery for a rare kidney cancer reduces the chance of cancer relapse by 50%. The recent study was published…

Continue Reading New Research Finds That Chemotherapy After Rare Kidney Cancer Surgery Reduces Chance of Relapse
Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study
source: pixabay.com

Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study

By Jodee Redmond from In The Cloud Copy The results of a case study have found that dantrolene can be used to treat involuntary muscle contractions (dystonia) in children with…

Continue Reading Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study
Acthar Gel Reduces Proteinuria for IgA Nephropathy Patients in Pilot Study
source: pixabay.com

Acthar Gel Reduces Proteinuria for IgA Nephropathy Patients in Pilot Study

According to a story from Yahoo Finance, the biopharmaceutical company Mallinckrodt recently released findings from an open label pilot study which tested the impact of Acthar Gel (corticotropin injection) as…

Continue Reading Acthar Gel Reduces Proteinuria for IgA Nephropathy Patients in Pilot Study
Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
source: pixabay.com

Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment

According to a story from businesswire.com, the Bristol Myers Squibb Company recently released the topline results from its phase 3 clinical trial. This study was testing a combination treatment consisting…

Continue Reading Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
Study Examines Neurological Differences in Cystinosis Patients
source: pixabay.com

Study Examines Neurological Differences in Cystinosis Patients

In a study published recently in the Orphanet Journal of Rare Diseases, a team of researchers identified distinct variations in the neuroanatomical and neuropsychiatric phenotypes of cystinosis patients. Phenotype refers to visible,…

Continue Reading Study Examines Neurological Differences in Cystinosis Patients
The Institute for Gene Therapies is Working to Improve Policy and Access for Charcot-Marie-Tooth Disease and Others
source: pixabay.com

The Institute for Gene Therapies is Working to Improve Policy and Access for Charcot-Marie-Tooth Disease and Others

The Institute for Gene Therapies (IGT) is a new development, aimed at improving the speed of development and accessibility of gene therapies. Gene Therapy Many rare diseases are caused by…

Continue Reading The Institute for Gene Therapies is Working to Improve Policy and Access for Charcot-Marie-Tooth Disease and Others
Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders
source: pixabay.com

Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders

  According to an article in BioPortfolio, Magenta Therapeutics, a biotechnology company based in Cambridge, Mass., recently announced updates to its Phase II trial of MGTA-456 for the treatment of…

Continue Reading Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders
Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities
source: pixabay.com

Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities

As originally reported in Biospace, two research networks dedicated to forming bridges between rare disease research around the world will share their niches to promote discovery for rare diseases. TriNetX…

Continue Reading Two Rare Disease Research Networks Combine to Connect Patients to Research Opportunities
Ethnobotanical Medicine is Proven to be an Effective Treatment for Lyme Disease
https://pixabay.com/en/thistles-flower-marianum-plants-1039039/

Ethnobotanical Medicine is Proven to be an Effective Treatment for Lyme Disease

Lyme disease is the most common vector-borne disease, and it has become more prominent due to climate change and urban developments spreading further into wooded areas. Treatment is typically effective…

Continue Reading Ethnobotanical Medicine is Proven to be an Effective Treatment for Lyme Disease